{"data":[{"accessionNo":"0001969223-26-000924","issuerCik":"0001664710","issuerName":"Keros Therapeutics, Inc.","ticker":"KROS","personName":"Newton Charles W.","relationship":"Director","securityClass":"Common","broker":"UBS Financial Services, Inc.","unitsToSell":551,"aggregateMarketValue":5719.38,"unitsOutstanding":19827188,"approxSaleDate":"2026-08-18","exchange":"NASDAQ","filedAt":"2026-08-18","canonicalUrl":"https://xoomar.com/markets/stocks/kros"},{"accessionNo":"0001969223-26-000680","issuerCik":"0001664710","issuerName":"Keros Therapeutics, Inc.","ticker":"KROS","personName":"Newton Charles W.","relationship":"Director","securityClass":"Common","broker":"UBS Financial Services, Inc.","unitsToSell":550,"aggregateMarketValue":5472.5,"unitsOutstanding":19791837,"approxSaleDate":"2026-06-11","exchange":"NASDAQ","filedAt":"2026-06-11","canonicalUrl":"https://xoomar.com/markets/stocks/kros"},{"accessionNo":"0001969223-26-000637","issuerCik":"0001664710","issuerName":"Keros Therapeutics, Inc.","ticker":"KROS","personName":"Knowles Julius","relationship":"Director","securityClass":"Common","broker":"UBS Financial Services, Inc.","unitsToSell":2625,"aggregateMarketValue":28035,"unitsOutstanding":19791837,"approxSaleDate":"2026-06-04","exchange":"NASDAQ","filedAt":"2026-06-04","canonicalUrl":"https://xoomar.com/markets/stocks/kros"},{"accessionNo":"0001969223-26-000636","issuerCik":"0001664710","issuerName":"Keros Therapeutics, Inc.","ticker":"KROS","personName":"Seth Alpna","relationship":"Director","securityClass":"Common","broker":"UBS Financial Services, Inc.","unitsToSell":2625,"aggregateMarketValue":28035,"unitsOutstanding":19791837,"approxSaleDate":"2026-06-04","exchange":"NASDAQ","filedAt":"2026-06-04","canonicalUrl":"https://xoomar.com/markets/stocks/kros"},{"accessionNo":"0001969223-26-000639","issuerCik":"0001664710","issuerName":"Keros Therapeutics, Inc.","ticker":"KROS","personName":"Farzan Nima","relationship":"Director","securityClass":"Common","broker":"UBS Financial Services, Inc.","unitsToSell":2625,"aggregateMarketValue":28035,"unitsOutstanding":19791837,"approxSaleDate":"2026-06-04","exchange":"NASDAQ","filedAt":"2026-06-04","canonicalUrl":"https://xoomar.com/markets/stocks/kros"},{"accessionNo":"0000947871-26-000370","issuerCik":"0001664710","issuerName":"Keros Therapeutics, Inc.","ticker":"KROS","personName":"OrbiMed Genesis Master Fund, LP","relationship":"Shareholder, Director","securityClass":"Common Stock","broker":"Themis Trading LLC","unitsToSell":45057,"aggregateMarketValue":497429.28,"unitsOutstanding":19717533,"approxSaleDate":"2026-03-31","exchange":"Nasdaq Stock Market","filedAt":"2026-03-31","canonicalUrl":"https://xoomar.com/markets/stocks/kros"}],"updatedAt":"2026-11-04T01:37:42.510Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/kros","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}